In 1976, as the US celebrated its 200 birthday, there was little fanfare around the birth of the Board of Pharmacy Specialties (BPS), in fact our birth name was Board of Pharmaceutical Specialties. The launch of BPS presaged the anticipated evolution of the pharmacy profession, as we embarked on a path of deeper clinical engagement to impact the safe and effective use of medications well before a prescription is written.
I am writing this edition of the BPS Leadership Blog as the 50th ASHP Midyear Clinical Meeting in New Orleans concludes. While the growth of this meeting from its humble beginnings in 1966 with less than a 1000 attendees to close to 25,000 people is remarkable, what is also remarkable is how our profession has developed over these 50 years.
The results of the fall 2015 BPS specialty certification and recertification exams were announced today by the Board of Pharmacy Specialties® (BPS), the premier post-licensure certification organization serving the pharmacy profession.
Board of Pharmacy Specialties Seeks BCCCP and BCPPS to Serve on its Specialty Councils Two Specialist Positions Available
Board of Pharmacy Specialties (BPS) today issues a Call for Nominations for two (2) Board Certified Critical Care Pharmacists (BCCCP) and two (2) Board Certified Pediatric Pharmacy Specialists (BCPPS) to serve on its Critical Care Pharmacy and Pediatric Pharmacy Specialty Councils, respectively.
On September 11, 2015 I departed Sacramento Airport for Vienna, Austria. The significance of the date did not escape me as I sat in the international terminal at LAX, waiting to board a 10-hour flight to Dusseldorf Germany.
Following the 2012 tragedy involving the New England Compounding Center (NECC) and other similar albeit smaller compounding misadventures, the public and healthcare professions pushed for improved safety of compounded drugs, primarily by seeking regulatory reform.
For many years the Board of Pharmacy Specialties (BPS) had five recognized specialties (Nuclear Pharmacy — 1978, Nutrition Support — 1988, Pharmacotherapy — 1988, Psychiatric Pharmacy — 1992, and Oncology — 1996).
Washington, DC – The Board of Pharmacy Specialties (BPS) recently approved a practice analysis or role delineation study in Sterile Compounding. Conducting a role delineation study is a critical step in evaluating a proposed specialty.